Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHVF

Recent news which mentions RHHVF

< Previous 1 2 3 4 5 Next >
FDA Approves Expanded Use Of Roche's Influenza Treatment
Tickers RHHBF RHHBY RHHVF
Tags Health Care Large Cap Biotech
From Benzinga
Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
Tickers AMGN MRK RHHBF RHHBY
Tags RHHBF AMGN RHHVF
From Benzinga
Poseida Shares Rally As Roche Takes Next Big Step Into Allogeneic CAR-T Field
Tickers PSTX RHHBF RHHBY RHHVF
Tags Health Care Contracts Biotech
From Benzinga
Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product
Tickers REGN RHHBF RHHBY RHHVF
Tags RHHBY General Price Target
From Benzinga
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
Tickers ABBV ABUS ASMB HLVX
Tags News TCDA Movers
From Benzinga
Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit
Tickers RHHBF RHHBY RHHVF
Tags Large Cap Biotech Health Care
From Benzinga
Roche Launches Dual Antigen & Antibody Hepatitis C Diagnostic Test
Tickers RHHBF RHHBY RHHVF
Tags News Briefs RHHBY
From Benzinga
New Data Reinforce Favorable Safety, Efficacy Of Roche's Hemlibra For Hemophilia A
Tickers RHHBF RHHBY RHHVF
Tags Market News RHHVF RHHBF
From Benzinga
Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial
Tickers RHHBF RHHBY RHHVF SRPT
Tags Movers Briefs News
From Benzinga
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
Tickers AMTI BIIB ESALF ESALY
Tags RHHBF ESALF General
From Benzinga
Roche-AC Immune's Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer's Patients
Tickers ACIU RHHBF RHHBY RHHVF
Tags Movers Briefs why it's moving
From Benzinga
Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients
Tickers BNTX MRK RHHBF RHHBY
Tags MRK Market News Benzinga
From Benzinga
Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer
Tickers MRK RHHBF RHHBY RHHVF
Tags News Briefs General
From Benzinga
Genentech's Tiragolumab/Tecentriq Fails On Progression Free Survival In PD-L1-High Metastatic Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags Benzinga RHHBF RHHVF
From Benzinga
Roche Releases More Evrysdi Data For Very Young Infants With SMA
Tickers RHHBF RHHBY RHHVF
Tags Biotech News Briefs
From Benzinga
Roche's CEO Warns Russia-Ukraine War Causing Problems For Multiple Sclerosis Trials
Tickers RHHBF RHHBY RHHVF
Tags RHHBF Benzinga RHHVF
From Benzinga
COVID-19 Tests Boost Roche's Q1 Sales, Reaffirms FY22 Outlook
Tickers RHHBF RHHBY RHHVF
Tags Health Care Biotech Large Cap
From Benzinga
EMA' Advisory Committee Recommends Approval For Roche's Two Cancer Drugs
Tickers RHHBF RHHBY RHHVF
Tags Health Care RHHBY General
From Benzinga
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
Tickers A ILMN MYGN NTRA
Tags Benzinga FDA NTRA
From Benzinga
Read Why Pliant Therapeutics Shares Are Soaring Today
Tickers PLRX RHHBF RHHBY RHHVF
Tags Biotech Health Care Market News
From Benzinga
Genentech's Ocrevus Shows Benefit In Disability Progression & Cognitive Decline In Multiple Sclerosis
Tickers RHHBF RHHBY RHHVF
Tags RHHBY General Health Care
From Benzinga
FDA Grants Priority Review To Roche's Actemra For Hospitalized COVID-19 Adults
Tickers RHHBF RHHBY RHHVF
Tags General COVID/19 Coronavirus RHHBY
From Benzinga
Roche's Tiragolumab Immunotherapy Flunks In Late-Stage Lung Cancer Trial
Tickers RHHBF RHHBY RHHVF
Tags News Biotech Phase 3 Trial
From Benzinga
Drug makers, Scientists Working For Long COVID Treatments: Reuters
Tickers AXLA GSK HGEN MRNA
Tags COVID/19 Coronavirus RHHBY General
From Benzinga
Roche's Evrysdi Shows Long-Term Efficacy, Safety In Broader Spinal Muscular Atrophy Population
Tickers PTCT RHHBF RHHBY RHHVF
Tags Market News RHHVF RHHBF
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
Tickers BAYRY BAYZF EXEL IPSEY
Tags RHHBF RHHVF BAYZF
From Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
Tickers ANY NVS REGN RHHBF
Tags NVS News SNY
From Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
Tickers NVS RHHBF RHHBY RHHVF
Tags Market News Benzinga Biotech
From Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
Tickers NVS RHHBF RHHBY RHHVF
Tags General RHHBY News
From Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
Tickers BIIB RHHBF RHHBY RHHVF
Tags Non Hodgkin Lymphoma Biotech Contracts
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.